Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
D3 Oncology Solutions, originally known as D3 Advanced Radiation Planning Services, is a specialized provider of radiation oncology services, including remote treatment planning and medical physics support. Founded as a subsidiary of UPMC (University of Pittsburgh Medical Center), the company was created to help cancer centers implement and optimize advanced radiation therapy technologies. Their expertise covers a wide range of clinical services, such as remote dosimetry for IMRT and VMAT, as well as comprehensive physics consulting and quality assurance. In 2015, the company was acquired by Varian Medical Systems to enhance Varian's software and services portfolio for the global oncology market. Today, D3 operates as a key clinical services unit within Varian, which is now a part of Siemens Healthineers. The organization continues to support healthcare providers in delivering high-quality, efficient radiation treatments to cancer patients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on D3 Advanced Radiation Planning Services.